FCM
CNCE

Farallon Capital Management’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

Farallon Capital Management’s Portfolio CNCE Stock Details CNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-58,700
Closed -$790K – 106
2014
Q1 		$790K Buy
+58,700
New +$790K 0.02% 82